These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7828250)

  • 1. Price stickers do not alter drug usage.
    Horrow JC; Rosenberg H
    Can J Anaesth; 1994 Nov; 41(11):1047-52. PubMed ID: 7828250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of price labeling of muscle relaxants on cost consciousness among anesthesiologists.
    Lin YC; Miller SR
    J Clin Anesth; 1998 Aug; 10(5):401-3. PubMed ID: 9702621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use inefficiency: a hidden source of wasted health care dollars.
    Gillerman RG; Browning RA
    Anesth Analg; 2000 Oct; 91(4):921-4. PubMed ID: 11004049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs.
    Szocik JF; Learned DW
    J Clin Anesth; 1994; 6(5):378-82. PubMed ID: 7986509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective audit of cost of sedation, analgesia and neuromuscular blockade in a large British ICU.
    Al-Haddad M; Hayward I; Walsh TS
    Anaesthesia; 2004 Nov; 59(11):1121-5. PubMed ID: 15479323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization pattern and cost of sedation, analgesia and neuromuscular blockade in a multidisciplinary intensive care unit.
    Hariharan S; Pillai G; Chen D; Soogrim S; Nelson J; Tsoi-a-Fatt R; Mohan K; Boodhai V
    West Indian Med J; 2008 Mar; 57(2):112-7. PubMed ID: 19565952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomics of neuromuscular blocking drugs: a perioperative cost-minimization strategy in children.
    Splinter WM; Isaac LA
    Anesth Analg; 2001 Aug; 93(2):339-44 , 3rd contents page. PubMed ID: 11473856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of anaesthesia with propofol ('Diprivan') or thiopentone and interactions with suxamethonium, atracurium and vecuronium.
    Nightingale P; Petts NV; Healy TE; Kay B; McGuinness K
    Postgrad Med J; 1985; 61 Suppl 3():31-4. PubMed ID: 2865719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic considerations in the use of neuromuscular blocking drugs.
    DeMonaco HJ; Shah AS
    J Clin Anesth; 1994; 6(5):383-7. PubMed ID: 7986510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/fentanyl/N2O anesthesia.
    Melloni C; Devivo P; Launo C; Mastronardi P; Novelli GP; Romano E
    Minerva Anestesiol; 2006 May; 72(5):299-308. PubMed ID: 16675938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple intervention to reduce the anesthetic pharmacy budget; the effect of price list stickers placed on vaporizers.
    Bucx MJ; Landman JJ; van Onzenoort HA; Kox M; Scheffer GJ
    J Clin Anesth; 2015 Jun; 27(4):307-10. PubMed ID: 25801163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
    Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
    Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sedative practice in intensive care units results of a Maghrebian survey].
    Kamel S; Tahar M; Nabil F; Mohamed R; Mhamed Sami M; Mohamed SB
    Tunis Med; 2005 Nov; 83(11):657-63. PubMed ID: 16422361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New muscle relaxants in outpatient anesthesiology.
    Goldberg M; Rosenberg H
    Dent Clin North Am; 1987 Jan; 31(1):117-29. PubMed ID: 3542610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.